文献速递睡眠呼吸障碍

重度阻塞性睡眠呼吸暂停与鼻腔微生物组改变及炎症增加相关

Severe Obstructive Sleep Apnea Is Associated with Alterations in the Nasal Microbiome and an Increase in Inflammation.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

该研究纳入WTCSNORE发现队列472人和Zaragoza睡眠验证队列93人,通过家庭睡眠测试诊断OSA,采集鼻腔灌洗液进行16S rRNA基因测序和炎症生物标志物检测。结果显示重度OSA患者鼻腔微生物组多样性和组成改变,富集链球菌、普雷沃菌和韦荣球菌,且微生物差异与炎症标志物相关,3个月持续气道正压通气治疗未改变鼻腔微生物组组成。

要点

  • 重度OSA患者鼻腔微生物组多样性及组成与疾病严重程度相关。
  • 重度OSA鼻腔微生物组富集链球菌、普雷沃菌和韦荣球菌。
  • 鼻腔微生物组差异与炎症生物标志物相关,但CPAP治疗3个月未改变微生物组。

核心结论

  • 重度OSA存在鼻腔微生物组改变,且与炎症标志物相关。
  • 需进一步实验探索微生物组与OSA炎症之间的因果关系。

研究设计与样本

  • 研究包含两个队列:发现队列为WTCSNORE队列472名受试者,验证队列为Zaragoza睡眠队列93名受试者。
  • 使用家庭睡眠测试诊断睡眠呼吸暂停。
  • 采集鼻腔灌洗液,基于16S rRNA基因测序分析微生物组组成,并检测炎症细胞、IL-8和IL-6等炎症生物标志物。
  • 验证队列获取了3个月纵向样本,包括必要时持续气道正压通气治疗后的样本。

主要发现

  • 在两个队列中,OSA严重程度与微生物组多样性和组成差异相关。
  • 重度OSA受试者鼻腔微生物组富集链球菌、普雷沃菌和韦荣球菌。
  • 鼻腔微生物组差异与炎症生物标志物相关。
  • 网络分析识别出共现微生物集群,定义微生物群落。
  • 多种常见口腔共生菌(如链球菌、罗氏菌、韦荣球菌和梭杆菌)与呼吸暂停低通气指数相关。

临床怎么用

  • 对于重度OSA患者,可关注鼻腔微生物组改变及其与炎症的关联。
  • CPAP治疗3个月未显示对鼻腔微生物组组成的改变,提示微生物组干预可能需额外策略。

局限性

  • 研究为观察性设计,无法确定微生物组改变与OSA炎症之间的因果关系。
  • 需进一步实验研究探索因果联系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Obstructive sleep apnea (OSA) is associated with recurrent obstruction, subepithelial edema, and airway inflammation. The resultant inflammation may influence or be influenced by the nasal microbiome. OBJECTIVES: To evaluate whether the composition of the nasal microbiota is associated with obstructive sleep apnea and inflammatory biomarkers. METHODS: Two large cohorts were used: 1) a discovery cohort of 472 subjects from the WTCSNORE (Seated, Supine and Post-Decongestion Nasal Resistance in World Trade Center Rescue and Recovery Workers) cohort, and 2) a validation cohort of 93 subjects rom the Zaragoza Sleep cohort. Sleep apnea was diagnosed using home sleep tests. Nasal lavages were obtained from cohort subjects to measure: 1) microbiome composition (based on 16S rRNA gene sequencing), and 2) biomarkers for inflammation (inflammatory cells, IL-8, and IL-6). Longitudinal 3-month samples were obtained in the validation cohort, including after continuous positive airway pressure treatment when indicated. MEASUREMENTS AND MAIN RESULTS: In both cohorts, we identified that: 1) severity of OSA correlated with differences in microbiome diversity and composition; 2) the nasal microbiome of subjects with severe OSA were enriched with Streptococcus, Prevotella, and Veillonella; and 3) the nasal microbiome differences were associated with inflammatory biomarkers. Network analysis identified clusters of cooccurring microbes that defined communities. Several common oral commensals (e.g., Streptococcus, Rothia, Veillonella, and Fusobacterium) correlated with apnea-hypopnea index. Three months of treatment with continuous positive airway pressure did not change the composition of the nasal microbiota. CONCLUSIONS: We demonstrate that the presence of an altered microbiome in severe OSA is associated with inflammatory markers. Further experimental approaches to explore causal links are needed.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Wu BG, Sulaiman I, Wang J, et al. Severe Obstructive Sleep Apnea Is Associated with Alterations in the Nasal Microbiome and an Increase in Inflammation. Am J Respir Crit Care Med. 2019. PMID: 29969291. doi:10.1164/rccm.201801-0119OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。